Contribution of eNOS variants to the genetic susceptibility of coronary artery disease in a Tunisian population

Genetic Testing and Molecular Biomarkers
Marwa Ben AliTouhami Mahjoub

Abstract

Nitric oxide (NO), produced by the enzyme endothelial nitric oxide synthase (eNOS), has critical roles in the regulation of vascular homeostasis and prevention of atherogenesis by inhibiting leukocytes, platelet activation, and smooth muscle cell proliferation. There is strong experimental and clinical evidence that abnormalities in eNOS availability play an important role in the pathophysiology of coronary artery disease (CAD). Controversial results regarding the association of eNOS gene polymorphisms with CAD have been reported. The aim of this study is to investigate the relationship of the 894G>T (rs1799983) and 4a/4b (rs61722009) polymorphisms of the eNOS gene with the presence of CAD in the Tunisian population. A total of 332 patients with CAD and 368 controls were included in this study. The 894G>T (rs1799983) single-nucleotide polymorphisms were analyzed by polymerase chain reaction-restriction fragment length polymorphism, and 4a/4b (rs61722009) polymorphism just by polymerase chain reaction (PCR). eNOS rs1799983 was significantly associated with CAD under the additive, dominant, but not recessive, models (additive model OR: 2.81; 95% CI [2.05-3.85]; p<0.001, dominant model OR: 2.84; 95% CI [2.09-3.86]; p<0.001, and re...Continue Reading

References

May 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·A J CayatteR A Cohen
Jan 1, 1993·Current Opinion in Nephrology and Hypertension·R M Palmer
Sep 4, 1999·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·H CaiX L Wang
Sep 13, 2002·The American Journal of Tropical Medicine and Hygiene·Nereida ValeroJesús A Mosquera
Jan 18, 2003·Current Hypertension Reports·Aroon D Hingorani
Jan 22, 2005·Journal of Hypertension·Hanspeter BrunnerUNKNOWN Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension
Feb 18, 2005·Nature Reviews. Genetics·Joel N Hirschhorn, Mark J Daly
Mar 8, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Selçuk MatyarTamer Inal
Apr 6, 2006·Clinical Medicine & Research·Zhihong Yang, Xiu-Fen Ming
Apr 18, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Priscilla C JaramilloLuis A Salazar
Feb 5, 2008·Diabetes Research and Clinical Practice·Hiroyuki TamemotoMasanobu Kawakami
Apr 17, 2008·Journal of Diabetes and Its Complications·Intissar EzzidiWassim Y Almawi
Nov 13, 2009·Diabetes Care·Daniele VersariStefano Taddei
Jan 20, 2010·Clinica Chimica Acta; International Journal of Clinical Chemistry·Irma Isordia-SalasGabriela Borrayo-Sánchez

❮ Previous
Next ❯

Citations

Nov 29, 2017·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Ahmed AmaraBrahim Nsiri
Aug 9, 2020·American Journal of Physiology. Heart and Circulatory Physiology·Jia ShiFan He
May 1, 2021·Genes·Sihle E MabhidaRabia Johnson
Jul 3, 2021·Journal of Clinical Medicine·Marwa Ben Ali GannounJulie L Lavoie
Apr 1, 2020·Journal of Vascular Research·Andrzej PawlikVioletta Dziedziejko

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

Genetic Power Calculator
SPSS
HPlus

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.